MS

Yet Another Reason That Sanofi-Genzyme Deal Will Go Through
BNET Pharma
Fri, 09/10/10 - 11:10 am
M&A
Sanofi
Genzyme
teriflunomide
MS
Campath
multiple sclerosis
Teva Wins Copaxone Protection
Forbes
Tue, 09/7/10 - 05:03 pm
Teva Pharmaceuticals
Copaxone
MS
multiple sclerosis
patents
Novartis
Momenta
Sanofi's Experimental Oral Multiple Sclerosis Treatment Reduces Relapses
Bloomberg
Mon, 08/30/10 - 11:18 am
Sanofi
MS
teriflunomide
Merck KGaA
multiple sclerosis
Novartis
Merck KGaA's Cladribine Multiple Sclerosis Pill Gets Faster Review in U.S.
Bloomberg
Wed, 07/28/10 - 10:22 am
Merck KGaA
multiple sclerosis
MS
cladribine
Novartis
Gilenia
Merck KGaA expects MS pill to lift drugs margin
Reuters
Wed, 06/30/10 - 10:00 am
Merck KGaA
multiple sclerosis
Gilenia
MS
Merck Serono
cladribine
Elan Faces Double Threat To Blockbuster Drug Tysabri
WSJ
Thu, 06/17/10 - 11:32 am
Elan
MS
Tysabri
Biogen Idec
Novartis
Gilenia
Genzyme's MS drug gets FDA fast track
Yahoo/AP
Tue, 06/15/10 - 09:15 am
fast track
Genzyme
MS
multiple sclerosis
FDA
FDA Approval Positions Novartis in the Lead to Bring Oral MS Treatment to Market
Seeking Alpha
Mon, 06/14/10 - 12:05 pm
FDA
Novartis
MS
multiple sclerosis
FDA Panel Endorses Novartis Multiple Sclerosis Pill
Pharmalot
Thu, 06/10/10 - 08:38 pm
FDA
advisory panels
Novartis
MS
multiple sclerosis
Gilenia
FDA weighs benefits, risks of Novartis MS pill
Yahoo/AP
Tue, 06/8/10 - 06:57 pm
MS
FDA
multiple sclerosis
Gilenia
Merck KGaA again seeks U.S. nod for MS pill
Reuters
Tue, 06/8/10 - 08:37 am
Merck KGaA
multiple sclerosis
MS
cladribine
Biogen Idec Sues Other MS Drug Makers
WSJ Online
Wed, 06/2/10 - 05:16 pm
MS
multiple sclerosis
Biogen Idec
Pfizer
Bayer
Novartis
patents
beta-interferon
Safety Concerns Unlikely to Delay FDA Approval of Novartis' MS Drug Gilenia
BNET Pharma
Wed, 06/2/10 - 08:25 am
Novartis
MS
multiple sclerosis
Gilenia
Biogen Starts Patient Enrollment
Yahoo/Zacks.com
Wed, 05/26/10 - 11:11 am
Biogen Idec
Abbott Laboratories
Acorda Therapeutics
daclizumab
Avonex
MS
FDA extends review on Novartis oral MS drug by three months
Pharma Times, UK
Tue, 05/25/10 - 09:02 am
FDA
Novartis
MS
multiple sclerosis
Gilenia
FDA Rejects 2nd Teva Citizen Petition Against Generic Copaxone
WSJ Online
Thu, 05/13/10 - 10:38 am
FDA
generics
Teva Pharmaceuticals
Copaxone
MS
multiple sclerosis
Teva's Double-Edged Sword
Motley Fool
Wed, 05/5/10 - 09:20 pm
Teva Pharmaceuticals
MS
Copaxone
generics
Mirapex
Boehringer Ingelheim
Ratiopharm
Novartis Races to Be First With Oral MS Drug
Seeking Alpha
Mon, 04/19/10 - 10:57 am
Novartis
multiple sclerosis
MS
Biogen Idec
Merck
Genzyme's Dilemma: Its Cheap Cancer Drug Wants to Cannibalize a Potential MS Blockbuster
BNET Pharma
Fri, 04/16/10 - 11:16 am
Genzyme
cancer
MS
multiple sclerosis
Campath
Positive MS data may thwart Icahn's plans for Genzyme
Fierce Biotech
Thu, 04/15/10 - 09:58 am
MS
multiple sclerosis
Campath
Carl Icahn
Genzyme

Pages